Wednesday, January 31, 2024

🌎 Plug Power Upgraded, Toast Initiated, Sarepta Therapeutics Initiated and more...

Ratings changes for Plug Power, Paramount Global, Core Scientific, eBay, TTM Technologies, TG Therapeutics, Sarepta Therapeutics and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
January 31st, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Advanced Micro Devices (NASDAQ:AMD) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $195.00 price target on the stock. This represents a 16.6% upside from the current price of $167.19.
  • Check Point Software Technologies (NASDAQ:CHKP) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $160.10.
  • Core Scientific (NASDAQ:CORZ) was upgraded by analysts at Compass Point from a "neutral" rating to a "buy" rating. They now have a $8.50 price target on the stock, up previously from $1.00. This represents a 176.0% upside from the current price of $3.08.
  • Commvault Systems (NASDAQ:CVLT) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $109.00 price target on the stock. This represents a 19.0% upside from the current price of $91.60.
  • Plug Power (NASDAQ:PLUG) was upgraded by analysts at Roth Mkm from a "neutral" rating to a "buy" rating. They now have a $9.00 price target on the stock, up previously from $4.50. This represents a 105.5% upside from the current price of $4.38.
  • Stryker (NYSE:SYK) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $360.00 price target on the stock. This represents a 7.1% upside from the current price of $336.13.
  • Stryker (NYSE:SYK) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $360.00 price target on the stock, up previously from $315.00. This represents a 7.1% upside from the current price of $336.13.
  • 2seventy bio (NASDAQ:TSVT) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $18.00 price target on the stock, up previously from $5.00. This represents a 257.1% upside from the current price of $5.04.
  • TechTarget (NASDAQ:TTGT) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $31.00. This represents a 29.5% upside from the current price of $34.76.
  • Vaxart (NASDAQ:VXRT) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $2.00 price target on the stock. This represents a 66.0% upside from the current price of $1.20.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • CF Industries (NYSE:CF) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $83.00 price target on the stock, down previously from $95.00. This represents a 9.0% upside from the current price of $76.12.
  • Deutsche Bank Aktiengesellschaft (NYSE:DB) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating.The current price is $13.04.
  • Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating.The current price is $5.57.
  • Johnson Controls International (NYSE:JCI) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating. They now have a $60.00 price target on the stock. This represents a 14.1% upside from the current price of $52.60.
  • LSB Industries (NYSE:LXU) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $11.00. This represents a 17.3% upside from the current price of $7.67.
  • M.D.C. (NYSE:MDC) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $63.00 price target on the stock, up previously from $57.00. This represents a 0.5% upside from the current price of $62.67.
  • New York Community Bancorp (NYSE:NYCB) was downgraded by analysts at Raymond James from a "strong-buy" rating to a "market perform" rating.The current price is $6.71.
  • Syndax Pharmaceuticals (NASDAQ:SNDX) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $23.00 price target on the stock, down previously from $36.00. This represents a 13.2% upside from the current price of $20.32.
  • Toyota Motor (NYSE:TM) was downgraded by analysts at Nomura from a "buy" rating to a "neutral" rating.The current price is $200.67.
  • United Parcel Service (NYSE:UPS) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $143.04.
  • Vertex Pharmaceuticals (NASDAQ:VRTX) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating.The current price is $432.61.
  • Vertex Pharmaceuticals (NASDAQ:VRTX) was downgraded by analysts at Robert W. Baird from a "neutral" rating to an "underperform" rating. They now have a $325.00 price target on the stock. This represents a 24.9% downside from the current price of $432.61.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $37.00 price target on the stock. This represents a 4.8% upside from the current price of $35.31.
  • GFL Environmental (NYSE:GFL) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $44.00 price target on the stock. This represents a 28.5% upside from the current price of $34.25.
  • Northwest Natural (NYSE:NWN) is now covered by analysts at Janney Montgomery Scott. They set a "neutral" rating and a $39.00 price target on the stock. This represents a 4.4% upside from the current price of $37.34.
  • Silence Therapeutics (NASDAQ:SLN) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $67.00 price target on the stock. This represents a 213.2% upside from the current price of $21.39.
  • Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $170.00 price target on the stock. This represents a 41.5% upside from the current price of $120.14.
  • Toast (NYSE:TOST) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating and a $19.00 price target on the stock. This represents a 5.6% upside from the current price of $18.00.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 American Consumer News, LLC dba MarketBeat.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: New Trump Bombshell

No comments:

Post a Comment

Can You Really Turn $10k Into $137k?

...